Stephen Galli
Director/Board Member bei ATOSSA THERAPEUTICS, INC.
Vermögen: 178 $ am 31.03.2024
Profil
Stephen J.
Galli is an Independent Director at Atossa Therapeutics, Inc., a Professor at Stanford University School of Medicine, and the President of the Association of Pathology Chairs.
He was formerly the President of the Collegium Internationale Allergologicum and the American Society for Investigative Pathology.
Galli received his doctorate from Harvard Medical School in 1973 and his undergraduate degree from Harvard College in 1968.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
15.03.2024 | 99 ( 0,00% ) | 178 $ | 31.03.2024 |
Aktive Positionen von Stephen Galli
Unternehmen | Position | Beginn |
---|---|---|
ATOSSA THERAPEUTICS, INC. | Director/Board Member | 01.07.2011 |
Stanford University School of Medicine | Corporate Officer/Principal | 01.02.1999 |
Association of Pathology Chairs | President | - |
Ehemalige bekannte Positionen von Stephen Galli
Unternehmen | Position | Ende |
---|---|---|
Collegium Internationale Allergologicum | President | - |
American Society for Investigative Pathology
American Society for Investigative Pathology BiotechnologyHealth Technology The American Society for Investigative Pathology operates as a biotechnology company. | President | - |
Ausbildung von Stephen Galli
Harvard Medical School | Doctorate Degree |
Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ATOSSA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Collegium Internationale Allergologicum | |
American Society for Investigative Pathology
American Society for Investigative Pathology BiotechnologyHealth Technology The American Society for Investigative Pathology operates as a biotechnology company. | Health Technology |
Association of Pathology Chairs |